Breaks Categories: News

WednesdayNov 11, 2020 10:49 am

NetworkNewsBreaks – SRAX Inc. (NASDAQ: SRAX) to Discuss Q3 Financials During Nov. 16 Call

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies, has announced an upcoming conference call. During the call, SRAX management will discuss the company’s Q3 financial report. The call is scheduled for Nov. 16, 2020, at 9 a.m. PT. SRAX founder and CEO Christopher Miglino and SRAX CFO Michael Malone will lead the call, which will provide an operational and financial summary of SRAX’s 2020 third-quarter numbers. Anyone interested in the presentation should register early to participate in the presentation; the live call can also be accessed by dialing  1-669-900-6833 and using the…

Continue Reading

WednesdayNov 11, 2020 10:21 am

NetworkNewsBreaks – Cybin Inc. (NEO: CYBN) Goes Public on Canada’s Next-Gen Stock Exchange

Cybin (NEO: CYBN), a leading Toronto-based biotech and life sciences company focused on psychedelic pharmaceutical therapies, today made its debut on the global public markets and is now trading on the NEO Exchange under the symbol “CYBN.” The company, which focuses on psychedelic drug development, unique delivery mechanisms, improved novel compounds and protocols, recently closed a C$45 million subscription receipt financing in relation to its reverse takeover transaction. This signified the largest subscription receipt financing in the Canadian psychedelic sector. “Today marks a meaningful milestone for our company, as our shares begin trading on the NEO Exchange under the ticker…

Continue Reading

WednesdayNov 11, 2020 9:19 am

NetworkNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Announces Plans to Present at Virtual Fall Investor Summit

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and health care platform, today announced that management will present at the Virtual Fall Investor Summit, hosted by Investor Summit Group and taking place November 16-18, 2020. According to the update, Trxade CEO Suren Ajjarapu is scheduled to participate in one-on-one meetings throughout the event and will host a virtual presentation at 2:30 p.m. Eastern Time (11:30 p.m. Pacific Time) on Tuesday, November 17, 2020. Interested parties may visit https://nnw.fm/frQ4P to register for the event and access the live webcast and archive of the presentation. To view the full press release,…

Continue Reading

TuesdayNov 10, 2020 2:40 pm

NetworkNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Announces Completion of Strategic Merger

180 Life Sciences (NASDAQ: ATNF, ATNFW), a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, today announced the successful closing of its transaction with KBL Merger Corp IV. Prior to the merger’s closing, KBL Merger Corp. changed its name to 180 Life Sciences Corp., and 180 Life Sciences Corp. changed its name to 180 Life Corp., which now operates as a wholly owned subsidiary of the company. As a result of the merger, the units and rights of KBL Merger Corp. ceased trading, and the shares of its…

Continue Reading

TuesdayNov 10, 2020 2:11 pm

NetworkNewsBreaks – The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) Expands A88CBD(TM) Ingestible Line with Innovative New Product

The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused drinking waters and CBD-infused products, today announced that its lifestyle brand A88CBD(TM) will introduce new powder packs in four exciting flavors available by the end of November. “We are thrilled to announce another exciting and innovative product for our A88CBD ingestible line,” said WTER president and CEO Ricky Wright. “Recently, we have added multiple category-leading items to our portfolio of products that differentiate us from competitors. Initial feedback has been overwhelmingly positive, resulting in strong online sales. Our latest addition, the A88CBD powder packs,…

Continue Reading

TuesdayNov 10, 2020 1:43 pm

NetworkNewsBreaks – InvestorBrandNetwork Announces New Stock2Me Podcast Episode Featuring Well-Known Author John Truman Wolfe

InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies to the investment community, has released its latest Stock2Me Podcast featuring John Truman Wolfe. Wolfe has authored two best-selling and international award-winning books: “The Coming Financial Crisis: A Look Behind the Wizard's Curtain” and “The 99 Strongest Banks in America.” Wolfe is also the editor and publisher of a monthly newsletter, titled “Strategic Financial Intelligence,” which focuses on investing, politics and the economy. During The Stock2Me Podcast episode, hosted by IBN’s Stuart Smith, Wolfe discussed the continued rise in mainstream appeal of decentralized cryptocurrencies following the launch of bitcoin in January 2009 as…

Continue Reading

TuesdayNov 10, 2020 1:38 pm

NetworkNewsBreaks – Creatd Inc. (NASDAQ: CRTD) to Discuss Q3 Financials, Business Update During Webcast

Creatd (NASDAQ: CRTD), the parent company of Vocal, a proprietary technology platform for creators of all types, will hold a Nov. 17 webcast. During the webcast, company officials will discuss Creatd’s third-quarter 2020 financial numbers as well as provide key updates about business updates, including an overview of CRTD’s freemium creator and paid subscription metrics. In addition, the company will host a Q&A following the discussion of the financials. Questions can be submitted via the webcast portal or emailed ([email protected]) prior to the webcast. Creatd anticipates releasing the company’s financial results after the market closes on Monday, Nov. 16, 2020. The…

Continue Reading

TuesdayNov 10, 2020 1:10 pm

NetworkNewsBreaks – Antibe Therapeutics Inc. (TSXV: ATE) (OTCQB: ATBPF) Graduates to the TSX

Antibe Therapeutics (TSXV: ATE) (OTCQB: ATBPF), a clinical stage company leveraging its unique hydrogen sulfide platform to develop safer medicines for pain and inflammation, today announced its receipt of final approval from the Toronto Stock Exchange (“TSX”) to list its common shares on the TSX. According to the update, Antibe’s shares will commence TSX trading under the company’s existing ticker symbol “ATE” at market open on Thursday, November 12, 2020. “We are excited to graduate to the TSX, as it represents a further step in reaching the broader investment community while increasing liquidity for our shareholders,” said Dan Legault, Antibe’s…

Continue Reading

TuesdayNov 10, 2020 12:49 pm

NetworkNewsBreaks – Sigma Labs Inc. (NASDAQ: SGLB) to Present at Virtual Fall Investor Summit

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial 3D metal printing industry, today announced that management will present at the Virtual Fall Investor Summit taking place from November 16 - 18, 2020. According to the update, Sigma Labs CEO Mark K. Ruport is scheduled to host a virtual presentation at 9:00 a.m. ET on Wednesday, November 18, 2020, and will also participate in one-on-one meetings throughout the day. Sigma’s presentation will highlight its new PrintRite3D Lite In-Process Quality Assurance system, IN4.OS Strategic Alliance for Factories of the Future and recent contract awards. Interested parties…

Continue Reading

TuesdayNov 10, 2020 12:25 pm

NetworkNewsBreaks – Cannabis Strategic Ventures (NUGS) Releases Quarterly Financials, Reports More Than 90% Increase in Sales

Cannabis Strategic Ventures (OTCQB:NUGS), an emerging leader in the U.S. cannabis marketplace, has announced its quarterly financial report for the period ending Sept. 30, 2020. A highlight of the report was the $6.4 million in sales for the period, a number that is up nearly 100% compared to the previous quarter, which totaled $3.3 million. Overall, the financial numbers indicate the company’s vigorous growth and wide-ranging expansion as it strengthens its position within the rapidly growing California cannabis marketplace. The increase in sales between the two quarters was more than 90%; the $6.4 million in sales represented a year-over-year increase…

Continue Reading